OncoMed Pharmaceuticals, Inc. to Present at 12th Annual Biotechnology Industry Organization (BIO) Investor Forum
10/4/2013 9:34:16 AM
REDWOOD CITY, Calif., Oct. 3, 2013 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, announced today that it will present at the 12th Annual BIO Investor Forum to be held at The Palace Hotel, San Francisco, CA on October 9, 2013at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time).
Help employers find you! Check out all the jobs and post your resume.